SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1 through SKP2 in Human Leukemia Cells-Reference-Cited by-同舟云学术

SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1 through SKP2 in Human Leukemia Cells

Published:2011-03 Issue:11 Volume:286 Page:9815-9825
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Bretones Gabriel,Acosta Juan C.,Caraballo Juan M.,Ferrándiz Nuria,Gómez-Casares M. Teresa,Albajar Marta,Blanco Rosa,Ruiz Paula,Hung Wen-Chun,Albero M. Pilar,Perez-Roger Ignacio,León Javier

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference72 articles.

1. Myc’s broad reach

2. Reflecting on 25 years with MYC

3. Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis?

4. Global mapping of c-Myc binding sites and target gene networks in human B cells

5. Genomic binding by theDrosophilaMyc, Max, Mad/Mnt transcription factor network

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks;Gene;2024-07

2. The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

3. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies;Frontiers in Oncology;2024-03-15

4. NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment;Immunology;2024-02-15

5. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products;Aging and disease;2024